-+ 0.00%
-+ 0.00%
-+ 0.00%
Claret Capital Partners provides EUR 30 million financing to Carvolix
Share
Listen to the news
Claret Capital Partners provides EUR 30 million financing to Carvolix
  • Claret Capital Partners committed EUR 30 million of debt financing to Carvolix to support commercialization of its TAVIpilot software.
  • Funding also targets industrialization across Carvolix’s medtech portfolio of AI-driven mini-robots and biomimetic implants for cardiology and ischemic stroke.
  • Carvolix is a listed French commercial- and clinical-stage medical technology company, formerly known as Affluent Medical.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claret Capital Partners Ltd published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending